Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05492903 · ClinicalTrials.gov registry record · NA
COMmunity of Practice And Safety Support for Navigating Pain (COMPASS-NP)
A NA study of Pain Management and Wounds and Injuries, sponsored by Oregon Health and Science University.
- Active
- Registry status
- NA
- Development phase
- 140
- Enrollment target
- 1
- Study location
NCT05492903: Active NA study of Pain Management and Wounds and Injuries, sponsored by Oregon Health and Science University.
NCT05492903 is a NA study of Pain Management and Wounds and Injuries that is active but no longer recruiting, run by Oregon Health and Science University. The registered enrollment target is 140 participants, roughly in line with the 150-participant average among 31 other Pain Management trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05492903, a NA study of Pain Management and Wounds and Injuries, is active but no longer recruiting, sponsored by Oregon Health and Science University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 140 participants
- Enrollment target
- 1
- Study location
Study Summary
Home care workers (HCWs) are at-risk for chronic pain and associated problems, including emotional distress, opioid use and misuse, and work-related disability. To address these issues, the proposed study will adapt an established peer-led and supportive group program to address the needs of HCWs with chronic pain. The new program, named COMPASS for Navigating Pain (COMPASS-NP), will integrate work-based injury protections with pain education and cognitive-behavioral therapy strategies for pain self-management in order to reduce pain interference with HCWs' work and life, and advance their safety, health, and well-being.
Primary Outcome
Work Limitations Questionnaire (1-5; 5=worst \[limited all the time\]). Assesses limitations related to time, physical, mental-interpersonal, and outputs.
Conditions Studied
Interventions
- BEHAVIORAL COMmunity of Practice And Safety Support for Navigating Pain (COMPASS-NP)
Study Locations (1)
Oregon
- Oregon Health & Science University - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 140 participants |
| Start Date | 2023-08-21 |
| Est. Completion | 2026-09 |
| Phase | NA |
What the registry record for NCT05492903 still lists
NCT05492903 is an interventional study that assigns participants to a tested intervention. The registered 140 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 150-participant average among 31 other Pain Management trials with a reported enrollment target.
The record links to 3 conditions, with Pain Management appearing as the primary indexed condition, and to 1 intervention - of which COMmunity of Practice And Safety Support for Navigating Pain (COMPASS-NP) is the first listed.
NCT05492903 reports a single indexed study location in Oregon.
Frequently Asked Questions
What is clinical trial NCT05492903 about?
NCT05492903 is a clinical study titled "COMmunity of Practice And Safety Support for Navigating Pain (COMPASS-NP)". Home care workers (HCWs) are at-risk for chronic pain and associated problems, including emotional distress, opioid use and misuse, and work-related disability. To address these issues, the proposed study will adapt an established peer-led and supportive group program to address the needs of HCWs wi...
What is the current status of trial NCT05492903?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 140 participants. The study started on 2023-08-21. Estimated completion is 2026-09.
What conditions does trial NCT05492903 study?
This clinical trial studies the following conditions: Pain Management, Wounds and Injuries, Ergonomics.
What interventions are being tested in trial NCT05492903?
The interventions under investigation include: COMmunity of Practice And Safety Support for Navigating Pain (COMPASS-NP) (BEHAVIORAL).
Who is sponsoring clinical trial NCT05492903?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05492903 being conducted?
This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain Management
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05492903's enrollment target sits among peer trials
140 13th of 31 higher than 19 of 31 other Pain Management trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pain Management trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
E-Tailored Pain Management Support for Dementia Family Caregivers: Feasibility of the PACE-app
RECRUITING · NA
-
mHealth Intervention for Pain Self Management
RECRUITING · NA
-
Sensory Spinal Cord Stimulation
RECRUITING · NA
-
Does Patient Testimonial Improve the Pain Relief Derived From a Brief Intervention
RECRUITING · NA
-
Post-Operative Analgesic Selection in Patients Planned for Third Molar Extraction After Undergoing Shared Decision Making Using 2- Versus 3-Option Decision-Aids
RECRUITING · NA
-
PEACE: Comparing Chronic Pain Treatment Options
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01419561 · 140 participants · Phase 2
Natural History Study of the KSHV Inflammatory Cytokine Syndrome (KICS)
- NCT01624805 · 140 participants · Phase 2
Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic Syndrome
- NCT02369770 · 140 participants · NA
Sensory-Motor Rehabilitation Post Stroke
- NCT02455193 · 140 participants · NA
Neuronal Effects of Exercise in Schizophrenia
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI